Other names: Repatha
Categories: Prescription Medication
Description:
Evolocumab (trade name Repatha) is a PCSK9 inhibitor used for patients with elevated cholesterol who require significant LDL reduction beyond what statins and other medications can provide. It works by blocking the PCSK9 protein, which increases the number of LDL receptors on the liver, allowing more LDL (“bad” cholesterol) to be removed from the blood. Administered as a subcutaneous injection every 2–4 weeks, evolocumab can lower LDL cholesterol by up to 60%. It is especially useful in patients with familial hypercholesterolemia or those with atherosclerotic cardiovascular disease who remain at high risk despite maximally tolerated statin therapy.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the treatment 'Evolocumab' against the disease 'Hypercholesterolemia'. The author has not provided any review or rating for this treatment. Therefore, it is not possible to determine the effectiveness of Evolocumab in treating Hypercholesterolemia without additional data or research.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
